Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

about

An in Vitro Assay of hERG K + Channel Potency for a New EGFR Inhibitor FHND004.Heparin Oligosaccharides Have Antiarrhythmic Effect by Accelerating the Sodium-Calcium Exchanger.

P2860

Q55175160-23D4A4B2-3805-472D-A932-7D6A813F1BC9 Q55399956-856BBAEC-9280-48B2-94A3-E691B40EFAE3

P2860

Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

Item

http://www.wikidata.org/entity/Q46607609

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@en

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@nl

type

Item

label

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@en

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@nl

prefLabel

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@en

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@nl

P1476

Have the Findings from Clinica ...... sages for Safety Pharmacology?

@en

P2093

Andrew Tinker

http://www.w3.org/2001/XMLSchema#string

Jem D Lane

http://www.w3.org/2001/XMLSchema#string

P2860

Antiarrhythmic drug therapy for atrial fibrillation

The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation

Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance

Effect of dronedarone on cardiovascular events in atrial fibrillation

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

Cellular basis of triggered arrhythmias in heart failure

Increased mortality after dronedarone therapy for severe heart failure

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

P304

890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2017.00890

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29163223

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

5681497

http://www.w3.org/2001/XMLSchema#string

Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

about

P2860

P2860

Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932